Compare WVE & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | BLZE |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 673.9M | 762.0M |
| IPO Year | 2015 | 2021 |
| Metric | WVE | BLZE |
|---|---|---|
| Price | $3.69 | $8.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 7 |
| Target Price | $17.11 | ★ $22.83 |
| AVG Volume (30 Days) | ★ 3.0M | 1.8M |
| Earning Date | 10-27-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.56 |
| EPS | N/A | ★ N/A |
| Revenue | $3,704,000.00 | ★ $145,835,000.00 |
| Revenue This Year | $46.45 | $18.60 |
| Revenue Next Year | N/A | $25.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 149.43 | 14.27 |
| 52 Week Low | $3.04 | $3.26 |
| 52 Week High | $21.73 | $23.99 |
| Indicator | WVE | BLZE |
|---|---|---|
| Relative Strength Index (RSI) | 51.82 | 31.67 |
| Support Level | $3.04 | $6.88 |
| Resistance Level | $4.07 | $9.46 |
| Average True Range (ATR) | 0.20 | 0.82 |
| MACD | 0.10 | -0.08 |
| Stochastic Oscillator | 76.83 | 9.92 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.